Predictions
Renewable Energy Group
Start price
Target price
Perf. (%)
€81.50
26.01.21
26.01.21
€100.00
2.45%
08.02.21
08.02.21
Risky Investment
Cummins Inc.
Start price
Target price
Perf. (%)
€204.00
26.01.21
26.01.21
€225.00
26.01.22
26.01.22
12.75%
08.03.21
08.03.21
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Sustainability is important
Orbital Infrastructure Group inc.
Start price
Target price
Perf. (%)
€350.00
26.01.21
26.01.21
€280.00
-19.43%
18.02.21
18.02.21
Could be very worthwhile Investment >20% year
Aemetis Inc.
Start price
Target price
Perf. (%)
€10.10
26.01.21
26.01.21
-
26.01.22
26.01.22
-20.79%
27.01.22
27.01.22
Innovative
High valuation
Low dividend yield expected
Below average Management
Orbital Infrastructure Group inc.
Start price
Target price
Perf. (%)
€274.00
26.01.21
26.01.21
-
26.01.22
26.01.22
-79.12%
27.01.22
27.01.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€35.05
25.01.21
25.01.21
-
25.01.22
25.01.22
-54.78%
06.08.21
06.08.21
Business model of the past or high risk
Higher risks for its business
Sunpower Corp.
Start price
Target price
Perf. (%)
€41.70
25.01.21
25.01.21
€46.00
25.01.22
25.01.22
-65.15%
26.01.22
26.01.22
Revenue growth > 30% per year expected
Could be worthwhile Investment >10% per year
Sustainability is very important
Future proof or reliable business model
Plug Power Inc.
Start price
Target price
Perf. (%)
€57.37
25.01.21
25.01.21
€55.00
25.01.22
25.01.22
-68.89%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Innovative
Very differentiated customer and product portfolio
Higher risks for its business
Orbital Infrastructure Group inc.
Start price
Target price
Perf. (%)
€212.00
25.01.21
25.01.21
€400.00
25.01.22
25.01.22
-49.43%
19.05.21
19.05.21
High risks for its business
overvalued
Little known brand
Metabolic Explorer
Start price
Target price
Perf. (%)
€2.79
25.01.21
25.01.21
€3.10
25.01.22
25.01.22
50.36%
22.06.21
22.06.21
Could be worthwhile Investment >10% per year
Polar Power Inc
Start price
Target price
Perf. (%)
€20.80
25.01.21
25.01.21
€18.00
25.01.22
25.01.22
-32.69%
28.01.21
28.01.21
Capable Management
Bad culture
Little innovation
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€199.00
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
-46.48%
17.01.22
17.01.22
Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
NVIDIA Corp.
Start price
Target price
Perf. (%)
€2.83
25.01.21
25.01.21
€3.44
25.01.22
25.01.22
24.13%
04.06.21
04.06.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
NVIDIA Corp.
Start price
Target price
Perf. (%)
€2.83
25.01.21
25.01.21
€3.44
25.01.22
25.01.22
24.13%
04.06.21
04.06.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
NVIDIA Corp.
Start price
Target price
Perf. (%)
€2.83
25.01.21
25.01.21
€3.44
25.01.22
25.01.22
24.13%
04.06.21
04.06.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€22.08
25.01.21
25.01.21
€35.00
30.39%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group